WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 15-July-2017 (data as of 11-July-2017)
Next overall update Fall-2017
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 2601 Infant (under 12 months) mortality rate: 542
GDP / capita (US$): 7361 Child (under 5 years) mortality rate: 822

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 10'524  10'199  9'892  9'600  9'320  6'401  5'415  4'117 
Births 447  437  427  417  406  274  271  209 
Surviving infants 415  405  395  385  374  247  239  184 
Pop. less than 5 years 1'901  1'853  1'803  1'757  1'709  1'154  1'089  775 
Pop. less than 15 years 4'723  4'564  4'412  4'270  4'134  3'157  2'569  1'821 
Female 15-49 years 2'477  2'408  2'344  2'283  2'223  1'388  1'207  974 

Number of reported cases

(Click for retrospective incidence data for Burundi)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  16  49  18'363  13'282  49'227 
Mumps
ChartChart
 
Pertussis
ChartChart
  72  529  9'613 
Polio*
ChartChart
  10  43 
Rubella
ChartChart
  29  79  71  11 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  16  25 
Tetanus (total)**
ChartChart
  33  65  256 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Burundi)
Vaccine year result method % card seen                                                
BCG 2011  98  EPI   51  93  93  92  95  98  73  97 
DTP1 2011  99  EPI   51  97  97  98  98  98  74 
DTP3 2011  98  EPI   51  94  94  95  96  96  68  86 
DTP4          42 
IPV1          60  60 
HepB_BD         
HepB3 2011  98  EPI   51  94  94  95  96  96 
Hib3 2011  98  EPI   51  94  94  95  96  96 
JapEnc         
MCV1          93  93  94  98  93  61  74 
MCV2          72  65  60  51 
MenA         
PCV1          97  97  98  98  99* 
PCV2          96  96  97  97  99* 
PCV3          94  94  95  96  99* 
Pol3 2011  98  EPI   51  94  94  95  96  96  69  97 
Rota1          97  97  98  14 
RotaC          96  96  96 
RCV1         
TT2plus 2009  32  DHS   62  90  90  80  96  88  28  56 
PAB         
VAD1          15  27  27 
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Burundi)
BCG
ChartChart
  93  93  92  95  98  85  97 
DTP1
ChartChart
  97  97  98  98  98  88  95 
DTP3
ChartChart
  94  94  95  96  96  80  86 
HepB3
ChartChart
  94  94  95  96  96 
HepB_BD
ChartChart
 
Hib3
ChartChart
  94  94  95  96  96 
IPV1
  60 
MCV1
ChartChart
  93  93  94  98  93  72  74 
MCV2
ChartChart
  72  65  60  51 
PCV3
ChartChart
  94  94  95  96  96 
Pol3
ChartChart
  94  94  95  96  96  71  97 
RCV1
 
RotaC
ChartChart
  96  96  96 
YFV
 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 46  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 76
From 80 to 89% 17
From 50 to 79% 7
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwP 18 months; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HPV 10 years; No
IPV 14 weeks; Yes
Measles 9, 18 months; Yes
MR 9, 18 months; Yes From May 2017
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10 weeks; Yes
Td 1st contact; +1,+6 months; +1, +1 year; Yes Pregnant women
YF 1st contact; Yes travellers

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number NA  2011-2015  2011-2015  2011-2015  2011-2015  2011-2015  2010-2014 
Nº of districts with microplans that include activities to raise immunization coverage number 46  45  45  45  45  45  45 

System performance

Total Nº districts in country number 46  45  45  45  45  45  45 
Nº districts with DTP3 coverage >=80% number 43  40  38  42  42  44  41 
% of districts with DTP3 coverage >=80% From 0 to 100% 93  89  84  93  93  98  91 
Nº districts with measles (MCV1) coverage >=95% number 30  18  20  27  31  29  16 
% of districts with MCV1 coverage >=95% From 0 to 100% 65  40  44  60  69  64  36 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  No  No  No  No  No  No 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  No  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100%     10 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR NA  No  No  No  No  No  No 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.